These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32491074)

  • 1. COVID-19 and Hypercoagulable State: A New Therapeutic Perspective.
    Nascimento JHP; Gomes BFO; Carmo JĂșnior PRD; Petriz JLF; Rizk SI; Costa IBSDS; Lacerda MVG; Bacal F; Hajjar LA; Oliveira GMM
    Arq Bras Cardiol; 2020 Jun; 114(5):829-833. PubMed ID: 32491074
    [No Abstract]   [Full Text] [Related]  

  • 2. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19.
    Joly BS; Siguret V; Veyradier A
    Intensive Care Med; 2020 Aug; 46(8):1603-1606. PubMed ID: 32415314
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).
    Marietta M; Ageno W; Artoni A; De Candia E; Gresele P; Marchetti M; Marcucci R; Tripodi A
    Blood Transfus; 2020 May; 18(3):167-169. PubMed ID: 32281926
    [No Abstract]   [Full Text] [Related]  

  • 4. 2020 - Year of COVID-19.
    Lillicrap D; Morrissey JH
    J Thromb Haemost; 2020 Sep; 18(9):2081. PubMed ID: 32881334
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticoagulation in COVID-19: DDI Perspective.
    Khiali S; Entezari-Maleki T
    Clin Appl Thromb Hemost; 2020; 26():1076029620959457. PubMed ID: 32936672
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia.
    Costanzo L; Palumbo FP; Ardita G; Antignani PL; Arosio E; Failla G;
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):711-716. PubMed ID: 32561465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?
    Nasiripour S; Zamani F; Farasatinasab M
    J Clin Pharmacol; 2020 Jul; 60(7):828-829. PubMed ID: 32445400
    [No Abstract]   [Full Text] [Related]  

  • 8. The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.
    Salah HM; Naser JA; Calcaterra G; Bassareo PP; Mehta JL
    Am J Cardiol; 2020 Nov; 134():155-157. PubMed ID: 32892991
    [No Abstract]   [Full Text] [Related]  

  • 9. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.
    Saini KS; Lanza C; Romano M; de Azambuja E; Cortes J; de Las Heras B; de Castro J; Lamba Saini M; Loibl S; Curigliano G; Twelves C; Leone M; Patnaik MM
    Br J Cancer; 2020 Sep; 123(5):694-697. PubMed ID: 32572174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboinflammation in COVID-19 acute lung injury.
    Mitchell WB
    Paediatr Respir Rev; 2020 Sep; 35():20-24. PubMed ID: 32653469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Ibuprofen in Patients With COVID-19: Causal or Confounded?
    Sodhi M; Etminan M
    Chest; 2020 Jul; 158(1):55-56. PubMed ID: 32243944
    [No Abstract]   [Full Text] [Related]  

  • 12. Position Statement on the Use of Antiplatelet Agents and Anticoagulants in Patients Infected with the New Coronavirus (COVID-19) - 2020.
    Soeiro AM; Leal TCAT; Pereira MP; Lima EG; Figueiredo ACBDS; Petriz JLF; Precoma DB; Serrano CV
    Arq Bras Cardiol; 2020 Aug; 115(2):292-301. PubMed ID: 32876200
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 update: Covid-19-associated coagulopathy.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 coagulopathy: an evolving story.
    The Lancet Haematology
    Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical Toxicology and COVID-19: Our Role in a Pandemic.
    Neumann NR; Chai PR; Wood DM; Greller HA; Mycyk MB
    J Med Toxicol; 2020 Jul; 16(3):245-247. PubMed ID: 32356251
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastrointestinal endoscopy during extracorporeal membrane oxygenation (ECMO) for COVID-19.
    Casper M; Lepper P; Danziger G; Reichert M; Seiler F; Bals R; Lammert F; Krawczyk M
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):471-473. PubMed ID: 32919427
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulation in Hospitalized Patients with Covid-19.
    Chowdhury JF; Moores LK; Connors JM
    N Engl J Med; 2020 Oct; 383(17):1675-1678. PubMed ID: 33085867
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19-associated coagulopathy.
    Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
    Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.
    Boonyasai RT; Murthy VK; Yuen-Gee Liu G; Garibaldi BT; Brotman DJ; Streiff MB; Omron R
    Mayo Clin Proc; 2020 Oct; 95(10):2291-2293. PubMed ID: 33012363
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of Atrial Fibrillation in COVID-19 Pandemic.
    Hu YF; Cheng WH; Hung Y; Lin WY; Chao TF; Liao JN; Lin YJ; Lin WS; Chen YJ; Chen SA
    Circ J; 2020 Sep; 84(10):1679-1685. PubMed ID: 32908073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.